Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection. | Korean J Intern Med | 2022 | 35417937 | PubTator, text mining | PubMed |
| Acute lymphoblastic leukemia-derived extracellular vesicles affect quiescence of hematopoietic stem and progenitor cells. | Cell Death Dis | 2022 | 35414137 | PubTator, text mining | PubMed |
| Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia. | Nat Commun | 2022 | 35411050 | PubTator, text mining | PubMed |
| Transcriptome analysis of adipocytokines and their-related LncRNAs in lung adenocarcinoma revealing the association with prognosis, immune infiltration, and metabolic characteristics. | Adipocyte | 2022 | 35410586 | PubTator, text mining | PubMed |
| Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging. | Int J Mol Sci | 2022 | 35409034 | PubTator, text mining | PubMed |
| Immune Checkpoint Receptors Signaling in T Cells. | Int J Mol Sci | 2022 | 35408889 | PubTator, text mining | PubMed |
| Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells. | Cancers (Basel) | 2022 | 35406494 | PubTator, text mining | PubMed |
| Tumor Microenvironment-Mediated Immune Profiles Characterized by Distinct Survival Outcome and Immunotherapeutic Efficacy in Breast Cancer. | Front Genet | 2022 | 35401704 | PubTator, text mining | PubMed |
| Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. | Front Immunol | 2022 | 35401516 | PubTator, text mining | PubMed |
| Defining Molecular Treatment Targets for Bladder Pain Syndrome/Interstitial Cystitis: Uncovering Adhesion Molecules. | Front Pharmacol | 2022 | 35401223 | PubTator, text mining | PubMed |
| ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer. | Front Cell Dev Biol | 2022 | 35399517 | PubTator, text mining | PubMed |
| Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy. | Stem Cell Res Ther | 2022 | 35395787 | PubTator, text mining | PubMed |
| Using a Machine Learning Approach to Identify Key Biomarkers for Renal Clear Cell Carcinoma. | Int J Gen Med | 2022 | 35392028 | PubTator, text mining | PubMed |
| Developmental maturation of the hematopoietic system controlled by a Lin28b-let-7-Cbx2 axis. | Cell Rep | 2022 | 35385744 | PubTator, text mining | PubMed |
| Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer. | Ann Med | 2022 | 35382656 | PubTator, text mining | PubMed |
| MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas. | Front Oncol | 2022 | 35372062 | PubTator, text mining | PubMed |
| Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy. | Front Immunol | 2022 | 35371071 | PubTator, text mining | PubMed |
| Comprehensive analysis of the correlations of S100B with hypoxia response and immune infiltration in hepatocellular carcinoma. | PeerJ | 2022 | 35368338 | PubTator, text mining | PubMed |
| CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. | J Exp Clin Cancer Res | 2022 | 35361234 | PubTator, text mining | PubMed |
| A Comprehensive Atlas of Immunological Differences Between Humans, Mice, and Non-Human Primates. | Front Immunol | 2022 | 35359965 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=49